Nephros (NEPH) Cost of Revenue (2016 - 2025)
Nephros has reported Cost of Revenue over the past 16 years, most recently at $2.0 million for Q4 2025.
- Quarterly results put Cost of Revenue at $2.0 million for Q4 2025, up 41.08% from a year ago — trailing twelve months through Dec 2025 was $7.2 million (up 31.72% YoY), and the annual figure for FY2025 was $7.2 million, up 31.72%.
- Cost of Revenue for Q4 2025 was $2.0 million at Nephros, up from $1.8 million in the prior quarter.
- Over the last five years, Cost of Revenue for NEPH hit a ceiling of $2.0 million in Q4 2025 and a floor of $991000.0 in Q2 2021.
- Median Cost of Revenue over the past 5 years was $1.4 million (2024), compared with a mean of $1.4 million.
- Biggest five-year swings in Cost of Revenue: soared 46.82% in 2022 and later decreased 15.83% in 2024.
- Nephros' Cost of Revenue stood at $1.2 million in 2021, then dropped by 15.54% to $1.0 million in 2022, then grew by 17.54% to $1.2 million in 2023, then increased by 13.14% to $1.4 million in 2024, then skyrocketed by 41.08% to $2.0 million in 2025.
- The last three reported values for Cost of Revenue were $2.0 million (Q4 2025), $1.8 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.